the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ringgit opens on softer note against US dollar

KUALA LUMPUR: The ringgit opened on a softer note against the US dollar on Monday as the greenback strengthened in light of the latest United States (US) nonfarm payrolls (NFP) data which surpassed expectations.

At 9 am, the ringgit eased to 4.6750/6800 against the greenback from last Friday’s close of 4.6625/6665.

According to reports, the US NFP numbers came in at 199,000 in November versus consensus estimates of 180,000.

However, Bank Muamalat Malaysia Bhd chief economist and social finance head Dr Mohd Afzanizam Abdul Rashid said upon further scrutiny, the sharp rise in the US NFP was mainly due to workers returning from their strike.

“In that sense, the labour market is softening, which could result in the Federal Open Market Committee (FOMC) members changing their tone when they reconvene on Dec 12-13.

“As for now, expect ringgit versus the US dollar to remain guarded,” he told Bernama.

Meanwhile, the ringgit was traded mostly lower versus a basket of major currencies.

It depreciated against the British pound to 5.8685/8748 from 5.8542/8593 at Friday’s close and weakened vis-a-vis the euro to 5.0359/0413 from 5.0243/0286 last week.

However, the ringgit strengthened against the Japanese yen to 3.2164/2200 from 3.2307/2337 previously.

At the same time, the ringgit traded mixed against other Asian currencies.

It stood unchanged versus the Philippines’ peso at 8.41/8.43 from Friday’s close, but increased against the Thai baht to 13.1283/1494 from 13.1933/2094.

The local note inched down versus the Singapore dollar to 3.4844/4884 from 3.4818/4853 last week, and went down against the Indonesian rupiah to 301.2/301.7 from 300.4/300.8 previously. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings